DISCOVER YOUR SIGNATURE LIFT
The Ulthera® System consists of three primary components:
The control unit with integrated touchscreen, the handpiece with cable, and interchangeable transducers.
Control Unit
- The control unit is the tabletop information center for the Ulthera® System.
- It houses the touchscreen monitor and Graphical User Interface (GUI) that allows the user to interact with the device.
- This screen sets and displays the operating conditions, including equipment activation status, treatment parameters, system messages and prompts, and ultrasound images.
Ultherapy PRIME is FDA‑cleared to lift the brow, the skin on the neck and under the chin, improve lines and wrinkles on the décolleté, and is additionally indicated to improve the appearance of skin laxity on the body, including the arms and abdomen.
Screen
- The Ultherapy PRIME platform stands out with distinct attributes to elevate your visualization experience.
- With a 19-inch screen and a 10-inch ultrasound panel, its unique imaging technology enables real-time visualization of your patient’s anatomy, allowing you to assess their individual needs and customize each treatment for optimal outcomes.
Ultherapy is the only technology that goes deeper than any other FDA-cleared ultrasound device, combining real-time imaging with a microfocused ultrasound to stimulate your body’s natural collagen production for a truly personalized long lasting lift, that can last up to a year or more.
Non-invasive. Zero downtime. One session. Long-lasting lift that can last up to a year or more.
Handpiece
- Ergonomically designed for precise control and reduction of grip fatigue during treatment, the handpiece works with six different Ultherapy ultrasound transducers.
- The handpiece is a handle with an integrated receptacle for insertion of a transducer on one end and an electrical cable for attachment to the control system on the other end. The handpiece has two types of buttons: one to image (SEE) and the other to deliver therapy (TREAT).
The Transducers
Ultherapy PRIME®’s patented DeepSEE® transducers provide simultaneous visualization and treatment.
- These multi-patient-use transducers treat at three separate depths-superficial dermis at 1.5mm, deep dermis at 3mm, and SMAS/platysma at 4.5mm. Tissues may be visualized with collimated ultrasound to 8mm.
Real-time visualization is crucial for ensuring safer and more effective treatments. By assessing each patient’s unique anatomical needs, you can select the appropriate transducer depths and ensure optimal coupling for enhanced safety. This allows for precise energy delivery to targeted tissue, resulting in a truly personalized lift.
